— Know what they know.
Not Investment Advice

ZY NASDAQ

Zymergen Inc.
1W: -8.7% 1M: -10.7% 3M: +13.0% 1Y: -80.7%
$2.43
Last traded 2022-10-18 — delisted
NASDAQ · Basic Materials · Chemicals - Specialty

Revenue Segmentation

By Product / Service

By Geography

Income Trends

Revenue
$17M +26.0% ▲
Gross Profit
-$53M +25.9% ▲
Operating Income
-$347M -43.9% ▼
Net Income
-$362M -38.0% ▼
EPS (Diluted)
$-4.87 -81.7% ▼
EBITDA
-$326M -40.3% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2019FY2020FY2021
Revenue$15M$13M$17M
YoY Growth+0.0%-13.8%+26.0%
Cost of Revenue$103M$85M$70M
Gross Profit-$87M-$72M-$53M
Gross Margin-565.7%-538.5%-316.4%
R&D Expenses$51M$91M$159M
SG&A Expenses$85M$79M$107M
Operating Expenses$136M$170M$266M
Operating Income-$237M-$241M-$347M
Operating Margin-1537.8%-1814.9%-2072.7%
Interest Expense$3M$11M$15M
Income Before Tax-$237M-$262M-$362M
Tax Expense$8K-$49K$51K
Net Income-$237M-$262M-$362M
Net Margin-1535.8%-1973.8%-2160.8%
EPS (Diluted)$-2.42$-2.68$-4.87
EBITDA-$219M-$233M-$326M
Shares Outstanding98M98M74M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms